| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 04.09. | Moderna's updated COVID-19 mRNA vaccine approved by MHRA | ||
| 03.09. | Novartis announces trial results for remibrutinib in relapsing multiple sclerosis | ||
| 03.09. | Inventiva appoints Chris Benecchi as Chief Operating Officer | ||
| 02.09. | Lilly to acquire Merida Biosciences in deal worth up to $2.875bn | ||
| 02.09. | Prescient completes integration of Uptake and Dolon under single global brand | ||
| 01.09. | AstraZeneca and Daiichi Sankyo's Enhertu plus pertuzumab approved in EU as first-line treatment for breast cancer | ||
| 01.09. | Why some stories change healthcare and others just generate noise | ||
| 28.08. | Genentech's US manufacturing facility advances with construction milestone | ||
| 28.08. | LEO Pharma elects Henriette Mersebach to the Board of Directors | ||
| 27.08. | FDA approves Revolution Medicines' first in class targeted therapy for metastatic pancreatic cancer | ||
| 27.08. | Envision Pharma Group appoints Ryan Tubbs as Senior Vice President, Commercial Growth | ||
| 26.08. | BriaCell advances personalised skin cancer immunotherapy vaccine candidate | ||
| 26.08. | VML Health appoints Sus Misra as Executive Director, Data & Analytics | ||
| 25.08. | Advanced Therapies Europe 2026 to put Europe's CGT competitiveness under the spotlight | ||
| 25.08. | BeOne Medicines, BeOne Care Foundation and The Max Foundation renew partnership | ||
| 24.08. | LEO Pharma acquires rights for dersimelagon from Tanabe Pharma | ||
| 24.08. | LEO Pharma acquire rights for dersimelagon from Tanabe Pharma | ||
| 24.08. | Lucid Group appoints Eric Muller as CEO | ||
| 21.08. | 'Switchable' smart gel may pave the way for next-gen drug delivery and sensing tech | ||
| 21.08. | Creating a strong patent portfolio through constant communication | ||
| 20.08. | Merck and Moderna announce potential new vaccine for melanoma | ||
| 20.08. | Leading through complexity | ||
| 19.08. | NICE recommends axunio's Axhidrox cream for adults with severe hyperhydrosis | ||
| 19.08. | The Amazon reckoning: GLP-1s and the consumer lifestyle shift - why the molecule is no longer enough | ||
| 18.08. | Lupus - moving patient care beyond current therapies towards resetting the immune system |